key: cord-0850332-mvgawvqq authors: Kang, Dominique; Ellgen, Clifford; Kulstad, Erik title: Possible effects of air temperature on COVID‐19 disease severity and transmission rates date: 2021-05-03 journal: J Med Virol DOI: 10.1002/jmv.27042 sha: 721d0d8780dd79d365020ab560a382daba7e1fd4 doc_id: 850332 cord_uid: mvgawvqq Currently available data are consistent with increased severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) replication at temperatures encountered in the upper airways (25–33°C when breathing room temperature air, 25°C) compared to those in the lower airways (37°C). One factor that may contribute to more rapid viral growth in the upper airways is the exponential increase in SARS‐CoV‐2 stability that occurs with reductions in temperature, as measured in vitro. Because SARS‐CoV‐2 frequently initiates infection in the upper airways before spreading through the body, increased upper airway viral growth early in the disease course may result in more rapid progression of disease and potentially contribute to more severe outcomes. Similarly, higher SARS‐CoV‐2 viral titer in the upper airways likely supports more efficient transmission. Conversely, the possible significance of air temperature to upper airway viral growth suggests that prolonged delivery of heated air might represent a preventative measure and prophylactic treatment for coronavirus disease 2019. The stability of viruses is affected by changes in temperature, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID- 19) , is no exception. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Heat denatures the proteins that comprise each SARS-CoV-2 virion, inactivating it. 3, 8 Laboratory data indicate that, as temperatures increase, the rate at which virions are inactivated increases exponentially. 3, 9 These in vitro data suggest that lower temperatures within the body might result in lower rates of thermal inactivation and therefore higher rates of viral growth, potentially affecting viral shedding, viral load densities, transmission rates, and patient outcomes. SARS-CoV-2 replicates abundantly in the upper airways, [11] [12] [13] and the temperature of the upper airways is directly affected by air temperature. Air below body temperature is warmed during inhalation through heat exchange with upper airway surfaces, reaching core body temperature (37°C) at the level of the lower airways. 14 This process cools the upper airways: Respiration of room temperature air (25°C) reduces the upper airways to an average ambient temperature of 33°C, which evolves from 25°C at the nasal vestibule to 34°C at the nasopharynx to approximately 37°C near the trachea. [15] [16] [17] Lower air temperatures as well as faster and deeper respiration cause further cooling. 16, [18] [19] [20] The airstream ordinarily rises to within 0.5°C of body temperature by the trachea, 14 making lower airway temperatures unique to the upper respiratory tract. Although complicating factors preclude the trivial extension of SARS-CoV-2 in vitro decay rates to the in vivo environment, currently available data support increased viral replication at the cooler temperatures of the upper airways relative to the warmer temperatures of the upper airways. [21] [22] [23] Abundant SARS-CoV-2 replication in the upper airways is a driver of its high transmissibility and is pivotal to the pathogenesis of COVID-19. 11 Figure 1 ). 3, 9 Complicating factors make the in vivo environment difficult to compare with the laboratory data currently available, and additional Rapid SARS-CoV-2 replication in the nasal cavity and upper airways may therefore contribute to greater and more rapid infection of the lower airways. Data on viral load are consistent with this hypothesis: SARS-CoV-2 upper respiratory tract viral load is strongly correlated with adverse outcomes and has been hypothesized to be a predictor of disease severity. 27 The nasopharyngeal viral load of severe COVID-19 cases has been found to be about 60 times higher than that of mild cases. 27 As such, factors that promote more rapid viral growth in the rates, warm air temperature and high relative humidity also facilitate a strong airway immune response, which could further contribute to the benefit of warm humidified air. 21, [33] [34] [35] [36] [37] [38] It is important to note that air above core body temperature is cooled during inhalation, limiting the effectiveness of very warm air in reducing viral stability in lower areas of the respiratory tract. It should also be noted that warm air does not warm the entire upper respiratory tract evenly but rather elevates the temperature range in the upper airways. 14 Temperature changes caused by respiration begin immediately, with the temperature of upper airway mucosal surfaces equilibrating within 7 min at resting respiratory rate. 19 The necessary air temperature and duration of treatment depend on the exposure dose. A larger exposure dose would require greater reduction to be reduced to less than infectious levels and for that reason it would require a longer treatment duration with warm air and/or a higher air temperature ( Figure 3B ). Importantly, prophylactic treatment with warm air need not reduce viral titer below infectious levels to be of potential benefit. The severity of many viral diseases is believed to be proportional to the initial viral inoculum. 94 Clinical studies conducted with influenza and coronaviruses indicate a dose-dependent increase in disease severity. 95, 96 Masks might reduce the inoculum exhaled by an infected host, and outbreaks of COVID-19 within populations where mask-wearing is enforced have resulted in lower rates of severe disease and fatality. 94, 97 This concept is consistent with clinical data on COVID-19 patients that indicate a strong correlation between upper respiratory tract viral load and disease severity. 27 Studies in the Syrian hamster model found that lower doses of administered SARS-CoV-2 virus led to less severe disease than higher doses. 98 Taken together, these data suggest that reduction of SARS-CoV-2 viral titer early after introduction to the upper airways may result in less severe disease. Similarly, reduced viral titer in the respiratory droplets expressed by that individual may result in less severe disease in naive hosts who contract COVID-19 from that infected individual. Currently available data are consistent with the hypothesis that warm air delivered early in the disease may reduce viral titer and prevent escalation of severity. An interventional study provided seven asymptomatic or pauci-symptomatic COVID-19 patients with 20 min of steam inhalation for 4+ consecutive days. 99 Symptomatic patients reported clinical improvement at the end of the protocol, and all patients tested negative after the first day of steam inhalation. This observation is preliminary-the study being limited in part by small sample size and the lack of a control group-and needs confirmation in a controlled trial, but the promising results suggest that further investigation of warm air as an early-stage treatment is warranted. Warm air delivery can be tolerated for long periods of time. Air that is humidified and heated to 37°C or 41°C and delivered via nasal high flow therapy (35 L/minute) for multiple hour-long sessions daily is well tolerated by healthy individuals. 100 Temperatures as high as 45°C are also well tolerated for prolonged periods. 93 Risks of aerosolizing SARS-CoV-2 must be considered when determining method of warm air delivery for COVID-19 patients. SARS-CoV-2 viral stability increases exponentially with decreases in temperature, as measured for virus in solution. 3, 9 The temperaturedependent decay rate suggests that cool air temperatures might enable increased rates of SARS-CoV-2 growth in the upper Clinical data support this concept: SARS-CoV-2 upper respiratory tract viral load is strongly correlated with adverse outcomes and has been hypothesized to be a predictor of disease severity. 27 Warm air delivery would need to occur for extended durations to suppress viral replication to a degree that would be beneficial, as decreases in virus infectivity are dependent on duration of exposure to elevated temperatures ( Figure 3B ). 3, 9 Warm, humidified air is welltolerated over long durations. 93, 100 It is important to note that air above body temperature will be cooled during inhalation, limiting the effectiveness of very warm air in reducing viral stability in lower areas of the respiratory tract. Care must be taken when administering air to COVID-19 patients to avoid aerosolizing viral particles. Postexposure prophylaxis applications may be of particular relevance for healthcare professionals who have insufficient personal protective equipment, as well as for populations who are at risk of more severe disease. There could also be opportunities for innovation in mask design to not only capture respiratory droplets and aerosolized viral particles, but also to warm inhaled air. Heating masks already exist and could be modified or directly applied to the aim of increasing thermal inactivation of virus in the upper respiratory tract. [101] [102] [103] [104] Even simple face masks have been shown to conserve heat loss from breathing and diminish upper airway cooling, 101 suggesting that simply increasing the duration of mask usage may be beneficial. Mask design and usage could be a promising area for innovation and further study. The impact of temperatures in the body on viral growth may help explain COVID-19 transmission rates and disease severity. Advances made in understanding the various impacts of temperature on COVID-19 could inform both disease prevention and treatment, with potentially significant impacts on patient outcomes and global disease burden. Erik Kulstad has equity interest in Attune Medical, a company involved in patient temperature management. Stability of SARS-CoV-2 in different environmental conditions Effect of environmental conditions on SARS-CoV-2 stability in human nasal mucus and sputum A predictive model of the temperature-dependent inactivation of coronaviruses Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review. Transbound Emerg Dis Increasing temperature and relative humidity accelerates Inactivation of SARS-CoV-2 on The effects of temperature and relative humidity on the viability of the SARS coronavirus Structural stability of SARS-CoV-2 degrades with temperature Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses Factors affecting stability and infectivity of SARS-CoV-2 SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract SARS-CoV-2 viral load in upper respiratory specimens of infected patients Virological assessment of hospitalized patients with COVID-2019 Pulmonary Ventilation. 12th edn. Guyton and Hall Textbook of Temperature profile in the nasal cavity Thermal mapping of the airways in humans Nasal mucosal temperature during respiration Intra-airway thermodynamics during exercise and hyperventilation in asthmatics A technique to measure the ability of the human nose to warm and humidify air Correlation of nasal mucosal temperature with subjective nasal patency in healthy individuals Disparate temperaturedependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility Temporal dynamics in viral shedding and transmissibility of COVID-19 Infection and rapid transmission of SARS-CoV-2 in ferrets Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients Viral dynamics in mild and severe cases of COVID-19 Determining the replication kinetics and cellular tropism of influenza D virus on primary welldifferentiated human airway epithelial cells Rhinoviruses replicate effectively at lower airway temperatures A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Für Gesamte Virusforsch Hemagglutinin cleavability, acid stability, and temperature dependence optimize influenza B virus for replication in human airways Link of a ubiquitous human coronavirus to dromedary camels Seasonality of respiratory viral infections Temperaturedependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells Exposure to cold and respiratory tract infections Low ambient humidity impairs barrier function and innate resistance against influenza infection Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa Two interferon-independent double-stranded RNA-induced host defense strategies suppress the common cold virus at warm temperature Increased virus shedding with aspirin treatment of rhinovirus infection Acetaminophen: more harm than good for chickenpox? Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers World Health Organization. Coronavirus disease (COVID-19): How is it transmitted Identifying airborne transmission as the dominant route for the spread of COVID-19 Transmission of SARS-CoV-2: a review of viral, host, and environmental factors Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units Comparative study of simulated nebulized and spray particle deposition in chronic rhinosinusitis patients High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Structural and functional basis of SARS-CoV-2 entry by using human ACE2 Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs Pathology and pathogenesis of severe acute respiratory syndrome The microbiome and the respiratory tract Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis The oral-lung axis: the impact of oral health on lung health Herpes simplex virus pneumonia: importance of aspiration etiology Gastric emptying and glycaemia in health and diabetes mellitus Diagnostic value of nasal secretions, current state: normal values. 1 Nasal mucociliary clearance in health and disease Quantitative aspiration during sleep in normal subjects Pharyngeal aspiration in normal adults and patients with depressed consciousness A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 Seasonality of viral infections: mechanisms and unknowns Are meteorological parameters associated with acute respiratory tract infections? Discussion on the common cold Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe Rapid Expert Consultation on SARS-CoV-2 survival in relation to temperature and humidity and potential for seasonality for the COVID-19 pandemic Weather variability and COVID-19 transmission: a review of recent research A spatio-temporal analysis for exploring the effect of temperature on COVID-19 early evolution in Spain Spatial analysis and GIS in the study of COVID-19. A review COVID-19 and the environment: a critical review and research agenda A review of the impact of weather and climate variables to COVID-19: in the absence of public health measures high temperatures cannot probably mitigate outbreaks Effects of temperature and humidity on the spread of COVID-19: a systematic review Investigation of effective climatology parameters on COVID-19 outbreak in Iran Effect of the social distancing measures on the spread of COVID-19 in 10 highly infected countries Multiple drivers of the COVID-19 spread: the roles of climate, international mobility, and region-specific conditions Genotyping coronavirus SARS-CoV-2: methods and implications Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. bioRxiv Spike mutation D614G alters SARS-CoV-2 fitness Estimated inactivation of coronaviruses by solar radiation with special reference to COVID-19 Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces Airborne SARS-CoV-2 is rapidly inactivated by simulated sunlight Effectiveness of N95 respirator decontamination and reuse against SARS-CoV-2 virus Indoor time-microenvironment-activity patterns in seven regions of Europe The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Equipment for airway warming in the treatment of accidental hypothermia Facial masking for COVID-19-potential for "Variolation" as we await a vaccine COVID-19: does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics? Med Hypotheses The time course of the immune response to experimental coronavirus infection of man Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19 Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development Thermal inactivation of SARS COVID-2 virus: are steam inhalations a potential treatment? Tolerability of nasal delivery of humidified and warmed air at different temperatures: a randomised double-blind pilot study An explanation for the seasonality of acute upper respiratory tract viral infections Heating and humidifying respiratory mask Cold weather face mask Respiratory heated face mask Possible effects of air temperature on COVID-19 disease severity and transmission rates